Another study collected the blood samples of 45 patients with early-stage PD and 20 healthy controls to measure IL-1β, IL-2, IL-6, IL-10, and TNF-α levels, with significantly lower levels of IL-2 and IL-6 in the control group than those in PD patients (Kim et al., 2022). This evidence concerns the gene IL1B and Parkinson disease.